Global Financial Private Capital’s Gilead Sciences GILD Stock Holding History

Global Financial Private Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2.66M	Sell	34,566 -80,192	-70%	-$6.15M	0.17%	128
2020 Q1	$8.59M	Buy	114,758 +4,509	+4%	+$312K	0.55%	56
2019 Q4	$7.16M	Sell	110,249 -15,122	-12%	-$985K	0.36%	80
2019 Q3	$7.95M	Buy	125,371 +121,529	+3,163%	+$7.94M	0.4%	75
2019 Q2	$260K	Buy	+3,842	New	+$253K	0.01%	249
2018 Q3	–	Sell	-3,182	Closed	-$225K	–	538
2018 Q2	$225K	Sell	3,182 -292	-8%	-$20.6K	0.01%	498
2018 Q1	$262K	Sell	3,474 -2,340	-40%	-$186K	0.01%	470
2017 Q4	$417K	Sell	5,814 -25	-0.4%	-$1.9K	0.01%	375
2017 Q3	$473K	Buy	+5,839	New	+$446K	0.02%	332

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Global Financial Private Capital's GILD Position: Q2 2020 in Review

Global Financial Private Capital reduced its Gilead Sciences (GILD) stake by 70% in Q2 2020, selling an estimated $6.15M and leaving 34,566 shares worth $2.66M. The position accounts for 0.17% of the portfolio, ranked #128.

Global Financial Private Capital first reported a position in GILD in Q3 2017 and has held it in 9 quarters since. The position peaked at $8.59M in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Global Financial Private Capital held 34,566 shares of Gilead Sciences worth $2.66M as of Q2 2020.
Global Financial Private Capital sold 80,192 Gilead Sciences shares in Q2 2020, an estimated $6.15M.
Gilead Sciences made up 0.17% of Global Financial Private Capital's portfolio in Q2 2020, its #128 holding.
Global Financial Private Capital first reported a position in Gilead Sciences in Q3 2017 and has held it in 9 quarters since.
Global Financial Private Capital's Gilead Sciences position peaked at $8.59M in Q1 2020.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.